SCHEMBL23733455

SCHEMBL23733455

CCc1ccc2c(n1)CCN(C(=O)CN1CC(O)C1)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
CASP1 P29466 2/20 0.38
CASP7 P55210 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALOX15 P16050 1/20 0.37
KDR P35968 6/20 0.37
CDK4 P11802 5/20 0.36
CDK2 P24941 5/20 0.36
CDK6 Q00534 5/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
CDK1 P06493 2/20 0.35
CDK7 P50613 2/20 0.35
CDK9 P50750 2/20 0.35
CCNB1 P14635 1/20 0.35
CCNE1 P24864 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23733460 0.92 KDM4E (0.40) ALDH1A1CASP1CASP7KDM4EMEN1
SCHEMBL23733458 0.92 KDM4E (0.40) ALDH1A1CASP1CASP7KDM4EMEN1
SCHEMBL21414420 0.90 CDK4 (0.38) ALDH1A1CASP1CASP7KDM4EMEN1
SCHEMBL23733456 0.90 KDM4E (0.43) ALDH1A1KDM4EMEN1KDRCDK4
SCHEMBL21414440 0.87 KDR (0.42) ALDH1A1KDM4EKDRCDK4CDK2
SCHEMBL21414488 0.86 KDR (0.36) ALDH1A1CASP1CASP7KDM4EMEN1
SCHEMBL23733485 0.86 KDR (0.48) ALDH1A1KDM4EMEN1KDRCDK4
SCHEMBL23733480 0.86 KDM4E (0.40) ALDH1A1CASP1CASP7KDM4EMEN1
SCHEMBL23733481 0.84 KDR (0.47) ALDH1A1KDM4EALOX15KDRCDK4
SCHEMBL23733486 0.83 KDR (0.42) ALDH1A1KDM4EKDRCDK4CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11084814-B2 Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof TEIJIN PHARMA LIMITED (JP) 2021-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11084814-B2 Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof CDK4, CDK6, CDK16 ALDH1A1 964/4885CASP1 2539/4885CASP7 1816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.